Cue Biopharma, Inc.CUENASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-83.89%
↑ 93% vs avg
Percentile
P70
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-1144.09%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -83.89% | +79.2% |
| 2024 | -404.09% | +51.8% |
| 2023 | -838.83% | +79.3% |
| 2022 | -4055.50% | -1233.4% |
| 2021 | -304.15% | +78.2% |
| 2020 | -1394.44% | -34.1% |
| 2019 | -1039.76% | +68.7% |
| 2018 | -3320.19% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |